India-based renal care major NephroPlus is rapidly transforming into a global powerhouse, with international markets now driving the company’s growth and profitability. Currently Asia’s only listed dialysis company—and one of just three globally—the Hyderabad-headquartered network is aggressively expanding its footprint far beyond its home market. Following the announcement of its FY26 financial results, group CEO Rohit Singh stated that the company aims to be recognized as a truly global dialysis network within the next five years.
NephroPlus, which is already the world’s fifth-largest dialysis network by scale, operates over 520 clinics across India, the Philippines, Saudi Arabia, Uzbekistan, and Nepal. The strategic shift toward overseas markets has yielded massive dividends. The share of international business in the company’s total revenue skyrocketed from approximately 12 percent in FY23 to nearly 42 percent in FY26. This exponential growth has been fueled by targeted acquisitions, government public-private partnership (PPP) projects, and entry into higher-realization markets.
The primary catalyst for this soaring profitability is the stark contrast in global treatment pricing. While a single dialysis session in India ranges between $22 and $25, markets like the Philippines yield roughly $110 per treatment. This pricing advantage, combined with favorable foreign exchange movements and a substantial 58 percent reimbursement hike in the Philippines, lifted NephroPlus’ blended revenue per treatment by 13.3 percent in FY26.
Financially, the company is stronger than ever. NephroPlus reported an FY26 revenue of ₹998.8 crore, marking a 32.2 percent year-on-year increase, while adjusted EBITDA rose 37.6 percent to ₹238.1 crore. Looking ahead, executives project a robust 15 to 20 percent compounded annual growth rate over the next three to four years, adding 40 to 50 clinics annually in India and 15 to 16 in the Philippines. Chief Financial Officer Prashant Goenka emphasized that international business is no longer just an add-on, but a core strategic pillar for the global giant.
